Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest news about EicOsis aggregated by PharmaCompass.com.

    Client Virtual Booth

    EICOSIS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    EicOsis
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    140 B Street, Suite 5, Number 346 Davis, CA 95616
    Telephone
    Telephone
    916-555-121
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.eicosis.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/eicosis/
    Twitter
    Twitter
    https://twitter.com/eicosis

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    EicOsis Initiates Phase 1b Clinical Trial of EC5026
    EicOsis Initiates Phase 1b Clinical Trial of EC5026

    https://www.prnewswire.com/news-releases/eicosis-initiates-phase-1b-clinical-trial-of-ec5026-302047230.html

    PR NEWSWIRE
    30 Jan 2024
    Share Share
    EicOsis Successfully Completes Phase 1a Clinical Trial of EC5026
    EicOsis Successfully Completes Phase 1a Clinical Trial of EC5026

    https://www.prnewswire.com/news-releases/eicosis-successfully-completes-phase-1a-clinical-trial-of-ec5026-301174243.html

    PRNEWSWIRE
    17 Nov 2020
    Share Share
    EicOsis EC5026 Granted Fast Track Designation by FDA for Neuropathic Pain
    EicOsis EC5026 Granted Fast Track Designation by FDA for Neuropathic Pain

    https://uk.advfn.com/stock-market/stock-news/82204527/eicosis-ec5026-granted-fast-track-designation-by-f

    ADVFN
    09 Apr 2020
    Share Share
    EicOsis Announces FDA Acceptance of IND Application for EC5026
    EicOsis Announces FDA Acceptance of IND Application for EC5026

    https://www.prnewswire.com/news-releases/eicosis-announces-fda-acceptance-of-ind-application-for-ec5026-the-first-soluble-epoxide-hydrolase-inhibitor-to-treat-pain-300935138.html

    PRNEWS WIRE
    10 Oct 2019
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search